Invitae Corporation (NVTA)


-0.00 (-0.26%)
Symbol NVTA
Price $0.5724
Beta 1.644
Volume Avg. 9.36M
Market Cap 163.989M
Shares () -
52 Week Range 0.36-2.94
1y Target Est -
DCF Unlevered NVTA DCF ->
DCF Levered NVTA LDCF ->
ROE 472.72% Strong Buy
ROA -269.22% Strong Sell
Operating Margin -
Debt / Equity -139.23% Sell
P/E -0.11 Neutral
P/B -0.15 Neutral


Consensus EPS

Upgrades & Downgrades

Latest NVTA news

Mr. Kenneth D. Knight
Diagnostics & Research
New York Stock Exchange

Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.